Antibiotic resistance poses a significant concern in modern healthcare, often leading to gastrointestinal (GIT) disorders and necessitating effective treatment options. Probiotic dietary supplements have emerged as a common approach to address these disorders. However, safety regulations mandate that probiotic strains used in such supplements should not harbor antibiotic resistance plasmids
Dmytriv et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: